ZyGEM Corp Ltd and Phthisis Diagnostics have announced that they have entered into an agreement to develop products enabling the detection of infectious pathogens in complex samples, such as stool, blood, and water.
Read MoreThe FDA has issued a second emergency use authorization (EUA) to Focus Diagnostics, the infectious disease diagnostics business of Quest Diagnostics Incorporated, for its 2009 H1N1 influenza virus test.
Read MoreOrtho Clinical Diagnostics announces FDA approval of a diagnostic assay for the detection of antibodies to human immunodeficiency virus (HIV) types 1+2 (Anti-HIV 1+2) for use on the VITROS 5600 Integrated and VITROS 3600 Immunodiagnostic Systems.
Read MoreGen-Probe Inc announces that it has signed a definitive agreement to acquire Prodesse Inc, a privately held leader in molecular testing for influenza and other infectious diseases, for approximately $60 million in cash.
Read More
CLP talks to Quidel’s new CEO, Douglas Bryant, about advances in respiratory virus testing and his longterm strategies for the company.
Read More